MR contrast developer Epix Medical has changed its corporate name to Epix Pharmaceuticals.
The name change, which was approved by stockholders at the company's annual meeting this May, is to better reflect the company's focus on developing pharmaceutical products, according to the Cambridge, MA-based firm.
By AuntMinnie.com staff writers
September 8, 2004
Related Reading
Epix begins testing blood clot imaging agent, August 6, 2004
Epix names Uprichard president and COO, July 16, 2004
Epix testing MS-325 for cardiac imaging, July 12, 2004
Epix launches new MS-325 trial, July 8, 2004
Schering submits MS-325 for EU approval, June 7, 2004
Copyright © 2004 AuntMinnie.com
